Difference between revisions of "Part:BBa K3714017"

Revision as of 03:44, 21 October 2021 (view source) Grus (Talk | contribs) ← Older edit		Latest revision as of 12:23, 21 October 2021 (view source) Grus (Talk | contribs)
(One intermediate revision by the same user not shown)
Line 3:		Line 3:
	<partinfo>BBa_K3714017 short</partinfo>		<partinfo>BBa_K3714017 short</partinfo>
−	An oligonucleotide designed to disinhibit the activity of an aptazyme (BBa_K3714010) in the existence of an inhibitor (BBa_K3714016). By TMSD reaction, the inhibitor should be removed from the aptazyme and the aptazyme can be used immediately.	+	An oligonucleotide designed to disinhibit the activity of an aptazyme (BBa_K3714010) in the existence of an inhibitor (BBa_K3714016). By TMSD reaction, the inhibitor should be removed from the aptazyme and the aptazyme can be used immediately. The validation of this part can be viewed in BBa_K3714016.<hr/>
	<!-- Add more about the biology of this part here		<!-- Add more about the biology of this part here
	===Usage and Biology===		===Usage and Biology===

---

Latest revision as of 12:23, 21 October 2021

Start oligo

An oligonucleotide designed to disinhibit the activity of an aptazyme (BBa_K3714010) in the existence of an inhibitor (BBa_K3714016). By TMSD reaction, the inhibitor should be removed from the aptazyme and the aptazyme can be used immediately. The validation of this part can be viewed in BBa_K3714016.

---

Sequence and Features